Business Context and Reporting Period
This Form 8-K Current Report was filed by Alpha and Omega Semiconductor Limited on April 8, 2013. The report discloses corporate governance changes, specifically the appointment of a new director to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel appointments and associated equity compensation.
Material Changes
- Board Appointment: Dr. King Owyang, Ph.D., was appointed to the Board of Directors, effective April 10, 2013.
- Equity Compensation: Dr. Owyang was granted an option to purchase 5,000 common shares under the Company's automatic grant program for non-employee directors.
- Option Terms: The exercise price is $9.19 per share (closing price on April 10, 2013). The option is immediately exercisable but subject to vesting conditions tied to the next regular annual shareholder's meeting.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on operations, or specific risk factors. The document notes that the option grant is subject to the Company's repurchase rights under the 2009 Share Option/Share Issuance Plan and will terminate early if Dr. Owyang ceases Board service.
Investor Verification Checklist
- Verify the exact vesting date of the 5,000 share option grant based on the timing of the next annual shareholder meeting.
- Review the full text of the 2009 Share Option/Share Issuance Plan (Exhibit 10.3 to Form F-1) for detailed repurchase rights and termination clauses.
- Confirm Dr. Owyang's specific committee assignments, which were noted as to be determined at a later date.
- Check the press release dated April 12, 2013 (Exhibit 99.1) for additional context on the appointment.